Compare AMP & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With more than $1 trillion in segment assets under management and advisory at year-end 2024, and with roughly 10,000 affiliated advisors, Ameriprise is one of the larger US-based wealth managers. The firm also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $645 billion in assets under management at year-end 2024. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.5 trillion in assets under management and advisory across segments at year-end 2024.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.